These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30877026)

  • 21. Changes of
    Iamjan SA; Thanoi S; Watiktinkorn P; Fachim H; Dalton CF; Nudmamud-Thanoi S; Reynolds GP
    Epigenomics; 2021 Jun; 13(12):953-965. PubMed ID: 34008409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglial and astrocytic changes in the striatum of methamphetamine abusers.
    Kitamura O; Takeichi T; Wang EL; Tokunaga I; Ishigami A; Kubo S
    Leg Med (Tokyo); 2010 Mar; 12(2):57-62. PubMed ID: 20110187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
    Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A
    Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.
    Sekine Y; Ouchi Y; Takei N; Yoshikawa E; Nakamura K; Futatsubashi M; Okada H; Minabe Y; Suzuki K; Iwata Y; Tsuchiya KJ; Tsukada H; Iyo M; Mori N
    Arch Gen Psychiatry; 2006 Jan; 63(1):90-100. PubMed ID: 16389202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use.
    Ernst T; Chang L
    J Neuroimmune Pharmacol; 2008 Sep; 3(3):165-72. PubMed ID: 18521756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propofol alleviates electroconvulsive shock-induced memory impairment by modulating proBDNF/mBDNF ratio in depressive rats.
    Zhang F; Luo J; Min S; Ren L; Qin P
    Brain Res; 2016 Jul; 1642():43-50. PubMed ID: 27017958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in serum orexin-A levels between the acute and subacute withdrawal phases in individuals who use methamphetamine.
    Lee WC; Chen PY; Kao CF; Huang MC
    Exp Clin Psychopharmacol; 2021 Dec; 29(6):573-579. PubMed ID: 32757597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand.
    Srisurapanont M; Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Jantamo P
    Drug Alcohol Depend; 2020 May; 210():107961. PubMed ID: 32302795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Function of complement factor H and imaging of small molecules by MALDI-MSI in a methamphetamine behavioral sensitization model.
    Xu J; Zhang Z; Liu R; Sun Y; Liu H; Nie Z; Zhao X; Pu X
    Behav Brain Res; 2019 May; 364():233-244. PubMed ID: 30731099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts.
    Södersten K; Pålsson E; Ishima T; Funa K; Landén M; Hashimoto K; Ågren H
    J Affect Disord; 2014 May; 160():1-9. PubMed ID: 24709015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.
    Sim MS; Soga T; Pandy V; Wu YS; Parhar IS; Mohamed Z
    Metab Brain Dis; 2017 Dec; 32(6):1767-1783. PubMed ID: 28681200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
    McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA
    Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic methamphetamine injection on levels of BDNF mRNA and its CpG island methylation in prefrontal cortex of rats.
    Salehzadeh SA; Mohammadian A; Salimi F
    Asian J Psychiatr; 2020 Feb; 48():101884. PubMed ID: 31830601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers.
    London ED; Berman SM; Voytek B; Simon SL; Mandelkern MA; Monterosso J; Thompson PM; Brody AL; Geaga JA; Hong MS; Hayashi KM; Rawson RA; Ling W
    Biol Psychiatry; 2005 Nov; 58(10):770-8. PubMed ID: 16095568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal.
    Su H; Zhang J; Ren W; Xie Y; Tao J; Zhang X; He J
    Medicine (Baltimore); 2017 Apr; 96(15):e6434. PubMed ID: 28403074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between serum malondialdehyde levels and depression during early methamphetamine withdrawal.
    Luan X; Chen H; Qiu H; Shen H; Zhao K; Ren W; Gu Y; Su H; Zhang J; Lv D; He J
    Neurosci Lett; 2018 Nov; 687():22-25. PubMed ID: 30219487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine-induced locomotor sensitization in mice is not associated with deficits in a range of cognitive, affective and social behaviours: interaction with brain-derived neurotrophic factor Val66Met genotype.
    Corrone M; Ratnayake R; de Oliveira N; Jaehne EJ; van den Buuse M
    Behav Pharmacol; 2023 Feb; 34(1):20-36. PubMed ID: 36373697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
    Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Laorden ML; Bailey A
    Neuropharmacology; 2016 Jun; 105():520-532. PubMed ID: 26896754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between interleukin-8 levels and the development of withdrawal symptoms during methamphetamine abstinence.
    Feng L; He W; Lin S; Ruan Y; Yuan C; Qiu H; Ren W; He J
    Hum Psychopharmacol; 2020 Jul; 35(4):e2736. PubMed ID: 32352600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine.
    Narita M; Aoki K; Takagi M; Yajima Y; Suzuki T
    Neuroscience; 2003; 119(3):767-75. PubMed ID: 12809697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.